AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

4,038
Mkt Cap
$4.15B
Volume
1.51M
52W High
$13.49
52W Low
$6.69
PE Ratio
912.68
AMRX Fundamentals
Price
$12.96
Prev Close
$13.20
Open
$13.19
50D MA
$12.11
Beta
1.18
Avg. Volume
1.88M
EPS (Annual)
-$0.3783
P/B
-37.21
Rev/Employee
$336,621.33
Loading...
Loading...
News
all
press releases
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High - Should You Buy?
Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 52-Week High - Time to Buy...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
ANIP Up 21% in 6 Months: Is It Worth Investing in the Stock Now?
ANI Pharmaceuticals' shares are up 21% in six months as strong 2025 results, repeated earnings beats and higher guidance highlight momentum in rare diseases.
Zacks·5d ago
News Placeholder
Allspring Global Investments Holdings LLC Boosts Stock Position in Amneal Pharmaceuticals, Inc. $AMRX
Allspring Global Investments Holdings LLC raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 1,440.0% in the 3rd quarter, according to the company in its most recent...
MarketBeat·5d ago
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Consensus Rating of "Moderate Buy" from Analysts
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five research firms that are covering the company, Marketbeat.com reports. One...
MarketBeat·17d ago
News Placeholder
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Analysts
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the five analysts that are currently covering the firm, Marketbeat reports. One...
MarketBeat·17d ago
News Placeholder
Assenagon Asset Management S.A. Raises Holdings in Amneal Pharmaceuticals, Inc. $AMRX
Assenagon Asset Management S.A. grew its holdings in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 187.1% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·22d ago
News Placeholder
Amneal Pharmaceuticals (NASDAQ:AMRX) Sets New 52-Week High - Still a Buy?
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High - Here's What Happened...
MarketBeat·24d ago
News Placeholder
Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Rating Upgraded by Barclays
Barclays upgraded Amneal Pharmaceuticals from an "overweight" rating to a "strong-buy" rating in a report on Monday...
MarketBeat·1mo ago
News Placeholder
JPMorgan Chase & Co. Buys 240,676 Shares of Amneal Pharmaceuticals, Inc. $AMRX
JPMorgan Chase & Co. raised its stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 22.0% during the second quarter, according to its most recent filing with the Securities and...
MarketBeat·1mo ago
News Placeholder
Arrowstreet Capital Limited Partnership Sells 96,228 Shares of Amneal Pharmaceuticals, Inc. $AMRX
Arrowstreet Capital Limited Partnership decreased its stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) by 5.4% during the second quarter, according to its most recent...
MarketBeat·1mo ago
<
1
2
...
>

Latest AMRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.